Analystreport

Dyne Therapeutics, Inc. (NASDAQ: DYN) was upgraded by analysts at Raymond James to a "strong-buy" rating.

Dyne Therapeutics, Inc.  (DYN) 
Last dyne therapeutics, inc. earnings: 11/1 04:30 pm Check Earnings Report
US:NYSE Investor Relations: dynegy.com/investors/presentations-events